Making Evidence Matter in the Marketplace: Applying Comparative Effectiveness to Health Technology A
|Event Date/Time: Nov 03, 2011||End Date/Time: Nov 04, 2011|
levels of evidence of comparative eff ectiveness applied within health technology assessments (HTAs). While the discussion of comparative
eff ectiveness research (CER) has been ongoing for years, the recent creation of the Patient-Centered Outcomes Research Institute (PCORI)
within health care reform, as well as new standards for evidence evaluation
development by leading payers have made understanding not just the theories, but rather their applications, of vital importance. This
meeting will push beyond the basic questions to evaluate the importance of CER and provide participants with actionable understandings
of how CER evidence can be better managed and developed within their own organizations.
This Fall we will address this gap within public conversation and understanding,
focusing less on defi nitions and theoretic concepts, and more on the application of CER and HTA within drug development and research planning. Unlike previous eff orts in this area, this meeting will provide participants with a â€œwhat does it mean for meâ€ perspective on
CER and HTA, providing them take-aways to apply within their day to-day drug development and marketing positions. Featured topics are likely to include discussions of pragmatic research designs for post-market applications, eff ective PRO development for payer needs,public and private payer perspectives of value, and specifi c approaches being taken within the marketplace to better align value and the research that supports it.